HSBC Holdings
CRBU icon

HSBC Holdings’s Caribou Biosciences CRBU Stock Holding History

HSBC Holdings’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.3K Hold
34,460
– – ﹤0.01% 2789
2025
Q4 		$55K Hold
34,460
– – ﹤0.01% 2858
2025
Q3 		$78.2K Sell
34,460
-80,183
-70% -$151K ﹤0.01% 2617
2025
Q2 		$147K Buy
114,643
+66,670
+139% +$65.6K ﹤0.01% 2772
2025
Q1 		$43.7K Sell
47,973
-63
-0.1% -$82 ﹤0.01% 2919
2024
Q4 		$74.7K Buy
48,036
+2,861
+6% +$5.75K ﹤0.01% 2938
2024
Q3 		$88.3K Sell
45,175
-35,692
-44% -$73.1K ﹤0.01% 2814
2024
Q2 		$129K Buy
80,867
+66,838
+476% +$214K ﹤0.01% 2684
2024
Q1 		$72.1K Buy
+14,029
New +$86.5K ﹤0.01% 2893

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HSBC Holdings's CRBU Position: Q1 2026 in Review

HSBC Holdings held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 34,460 shares worth $65.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

HSBC Holdings first reported a position in CRBU in Q1 2024 and has held it in 9 quarters since. The position peaked at $147K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • HSBC Holdings held 34,460 shares of Caribou Biosciences worth $65.3K as of Q1 2026.
  • HSBC Holdings left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2789 holding.
  • HSBC Holdings first reported a position in Caribou Biosciences in Q1 2024 and has held it in 9 quarters since.
  • HSBC Holdings's Caribou Biosciences position peaked at $147K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.